Current Atherosclerosis Reports

Article	Citations
Revascularization Options for Left Main Disease: What Clinicians Need to Know	113
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?	107
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes	102
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions	86
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management	84
Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?	64
A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment	64
Watermelon and l-Citrulline in Cardio-Metabolic Health: Review of the Evidence 2000–2020	63
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis	63
Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease	63
Heart Transplant, Kawasaki Disease, and Bone Marrow Transplant: Are There Consequences?	63
The Role of the PI3K/Akt/mTOR Pathway in Atherosclerosis: Mechanisms, Therapeutic Potential, and Emerging Targeted Treatments	61
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management	54
The Effects of FABP4 on Cardiovascular Disease in the Aging Population	54
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?	53
Effects of Pioglitazone On Lipoprotein(a): A Meta-analysis	50
Salutary Effects of Nutritional Ketosis for the Diseased Human Heart	50
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women	46
Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event	45
DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm	44
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice	44
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond	41
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators	39
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?	37
The Emerging Specialty of Cardio-Rheumatology	36

Recent Advances and Perspectives of Metabolomics-Based Investigations in Coronary Heart Disease	35
Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?	34
Percutaneous Coronary Interventions in Women	34
Correction to: Beta‑blockers for Atherosclerosis Prevention: a Missed Opportunity?	34
The Role of Sleep in Cardiovascular Disease	34
Programmable Genome-Editing Technologies as Single-Course Therapeutics for Atherosclerotic Cardiovascular Disease	34
Inflammation in the Peri-ACS Period: Ready for Prime Time?	33
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women	32
The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review	31
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention	30
GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?	30
Myeloid Cells in Abdominal Aortic Aneurysm	29
Lipoprotein(a): from Causality to Treatment	28
Low LDL-C: Is It all Good News?	28
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease	27
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?	26
The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger	25
Importance of Nutrition Security to CVD Prevention Efforts in the USA	25
Transgender Cardiovascular Health: Practical Management for the Clinician	24
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know	24
Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis	23
Update on Plant-Based Diets and Cardiometabolic Risk	23
Childhood Hypertriglyceridemia: Is It Time for a New Approach?	23
Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion	23
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment	22
Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis	22
Correction to: High-Density Lipoproteins and Serum Amyloid A (SAA)	21
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?	21
Transforming Population Health Screening for Atherosclerotic Cardiovascular Disease with AI-Enhanced ECG Analytics: Opportunities and Challenges	20
Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?	20
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity	20
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference	20
Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction	18
Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols	18
SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor	18
Dairy Foods: Is Its Cardiovascular Risk Profile Changing?	18
Exploring the Role of SPARC in Atherosclerosis: Mechanisms and Potential Implications	18
Evidence Gaps in Assessments of the Healthiness of Online Supermarkets Highlight the Need for New Monitoring Tools: a Systematic Review	18
Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease	18
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?	17
Cardiovascular Disease in the Middle East and North Africa, 1990–2021: Burden, Trends, and Risk Factors	17
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference	17
Is There a Role for Imaging Youth at Risk of Atherosclerosis?	17
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?	17
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know	16
Gene Regulatory Networks in Coronary Artery Disease	16
Clinical Management of Dyslipidemia in Infants and Toddlers	16
HIV and Cardiovascular Disease Burden in Young Adults (18–25 years): A Review of Current Evidence	16
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population	16
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precision Medicine	16

Cardiovascular Health and Disease in the Pakistani American Population	16
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis	16
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference	15
Expanding Clinical Indications for Cardiac CT: A Review of Its Current Utility in American and European Guidelines	15
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults	15
Targeting the Gut Microbiome to Treat Cardiometabolic Disease	15
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field	15
What Causes Premature Coronary Artery Disease?	15
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review	15
Natural Sirtuin1 Activators and Atherosclerosis: an Overview	14
Utility of FFRCT in Patients with Chest Pain	14
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins	14
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician	14
The Role of Lysyl Oxidase in the Pathological Stage of Atherosclerosis: Structural Stabilizer or Disease Driver?	14
Serial Coronary CTA for Monitoring Response to Lipid-Lowering Therapy: A Narrative Review	14
Bempedoic Acid: for Whom and When	14
Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men	14
Dietary Management of Atherogenic Dyslipidemia	14
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms	14
Fixed Combination for the Treatment of Dyslipidaemia	13
Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?	13
Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments	13
Circular RNA role in Atherosclerosis Development and Progression	13
Correlation Between Oral Bacteria and Atherosclerotic Thrombotic Disease: Advances in Animal Model Studies	13
Combined Dyslipidemia in Children and Adolescents: a Proposed New Management Approach	12
Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches	12
Diet, Food Insecurity, and CVD Risk in Sexual and Gender Minority Adults	12
LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?	12
Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk	12
Lipids: a Potential Molecular Pathway Towards Diastolic Dysfunction in Youth-Onset Type 2 Diabetes	12
Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention	12
Statins and Inflammation	12
Apheresis: What Should a Clinician Know?	12
Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk	12
Non-obstructive Plaque and Treatment of INOCA: More to Be Learned	12
Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis	12
Glycated Hemoglobin as an Integrator of Cardiovascular Risk in Individuals Without Diabetes: Lessons from Recent Epidemiologic Studies	11
Obicetrapib—the Rebirth of CETP Inhibitors?	11
Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation	11
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia	11
The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia	11
HDL as a Treatment Target: Should We Abandon This Idea?	10
S-Nitrosylation: Mechanistic Links between Nitric Oxide Signaling and Atherosclerosis	10
Advances, Challenges, and Progress in Cardiac Rehabilitation in Chronic CVD Management	10
European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges	10
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions	10
Recent Advances in Coronary Computed Tomography Angiogram: The Ultimate Tool for Coronary Artery Disease	10
Unveiling the Sex-Based Divide: Exploring Sex Differences in Peripheral Artery Disease	10
Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?	10
The TICE Pathway: Mechanisms and Potential Clinical Applications	10
Cardiovascular Disease Burden among African Migrants	10
Can Digital Health Solutions Fill in the Gap for Effective Guideline Implementation in Cardiovascular Disease Prevention: Hope or Hype?	10
Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy	10
Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications	10
Imaging Approaches to the Diagnosis of Vascular Diseases	10
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target	9
Targeting Inflammatory Pathways in Atherosclerosis: Exploring New Opportunities for Treatment	9
An Update on Nutrition Guidance for Cardiovascular Health	9
CETP Inhibitors: Should We Continue to Pursue This Pathway?	9
Psychological Health and Ischemic Heart Disease in Women: A Review of Current Evidence and Clinical Considerations across the Healthspan	9
Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence	9
Statin Use and Hyperglycemia: Do Statins Cause Diabetes?	9
How to Handle Elevated Triglycerides: Life after PROMINENT	9
Cholesterol Lowering in Older Adults: Should We Wait for Further Evidence?	9
Artificial Intelligence-Enabled Point-of-Care Echocardiography: Bringing Precision Imaging to the Bedside	8
JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis	8
Myocardial Bridge and Atherosclerosis, an Intimal Relationship	8
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?	8
Update on Sitosterolemia and Atherosclerosis	8
Mechanisms Behind NAFLD: a System Genetics Perspective	8
LDL Transcytosis by the Arterial Endothelium—Atherosclerosis by a Thousand Cuts?	8
Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?	8
Ancestral Variation in Lp(a): Epidemiology, Isoform Diversity, and Testing	8
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes	8
Correction to: Built Environment and Cardiovascular Diseases – Insights from a Global Review	8
Gene Editing for the Treatment of Hypercholesterolemia	8
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?	8
Family Meals and Cardiometabolic Risk Factors in Young Children	8
Achieving More Optimal Lipid Control with Non-Statin Lipid Lowering Therapy	8
More than Just a Monolayer: the Multifaceted Role of Endothelial Cells in the Pathophysiology of Atherosclerosis	8

Correction to: Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?	8
Sport as Medicine for Dyslipidemia (and Other Risk Factors)	7
Correction to: Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?	7
Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes	7
“Anti-inflammatory Therapies in Atherosclerosis – Where are we going?”	7
Incidental Finding of Coronary and Non-Coronary Artery Calcium: What Do Clinicians Need To Know?	7
Are Glucagon-Like Peptide 1 Receptor Agonists and Bariatric Surgery the Answer to Childhood Obesity?	7
Transitioning Adolescents and Young Adults with Lipid Disorders to Adult Health Care	7
Eggs and Cardiovascular Disease Risk: An Update of Recent Evidence	7
ADAMTS7: a Novel Therapeutic Target in Atherosclerosis	7
Biomarkers Differentiating Plaque Erosion from Stable Plaque	7
Health Literacy is Essential to ASCVD Prevention in Youth	7
The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder	7
Familial Combined Hyperlipidemia: Myth or Reality?	7
Built Environment and Cardiovascular Diseases – Insights from a Global Review	6
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future	6
Sex-based Differences in Complications Following Percutaneous Coronary Interventions	6
Tackling the Cardio-Kidney-Metabolic Burden in Cancer	6
Inclisiran: How Widely and When Should We Use It?	6
Alcohol Consumption and Cardiovascular Disease Risk: Placing New Data in Context	6
Effects of the COVID-19 Pandemic on Pediatric and Adolescent ASCVD Risk Factors	6
Insight into the Mechanistic role of Colchicine in Atherosclerosis	6
Statin Intolerance: an Overview of US and International Guidance	6
Updates in Small Interfering RNA for the Treatment of Dyslipidemias	6
Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)	6
Invasive Coronary Assessment in Myocardial Ischemia with No Obstructive Coronary Arteries	6
Impact of Sex Differences on Lipids and Statin Utilization	6
Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease	6
The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations	6
Rap1 in the Context of PCSK9, Atherosclerosis, and Diabetes	6
The Role of Non-statin Lipid-Lowering Medications in Youth with Hypercholesterolemia	6
Mechanosensing and Mechanosignal Transduction in Atherosclerosis	6
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?	5
Medical Nutrition Therapy Provided by Dietitians is Effective and Saves Healthcare Costs in the Management of Adults with Dyslipidemia	5
Telomere Length: Implications for Atherogenesis	5
Novel Therapeutics for Familial Chylomicronemia Syndrome	5
AI in Adipose Imaging: Revolutionizing Visceral Adipose Tissue, Ectopic Fat, and Cardiovascular Risk Assessment	5
T-cell Cholesterol Accumulation, Aging, and Atherosclerosis	5
SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently?	5
Saturated Fat and Cardiovascular Health: Phenotype and Dietary Factors Influencing Interindividual Responsiveness	5
From Gut Inflammation to Cardiovascular Conflagration: Mapping IBD’s Cardiometabolic Risks	5
The Pandemic of Coronary Heart Disease in the Middle East and North Africa: What Clinicians Need to Know	5
The Role of Genetics in Advancing Cardiometabolic Drug Development	5
N-3 Fatty Acids (EPA and DHA) and Cardiovascular Health - Updated Review of Mechanisms and Clinical Outcomes	5
Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies	5
Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?	5
Ultra-processed Foods and Cardiometabolic Health Outcomes: from Evidence to Practice	5
Medication Induced Dyslipidemia in Children	5
Updates in Drug Treatment of Severe Hypertriglyceridemia	5
Lp(a): A Rapidly Evolving Therapeutic Landscape	5
Protective Effects of Different Classes, Intensity, Cumulative Dose-Dependent of Statins Against Primary Ischemic Stroke in Patients with Type 2 Diabetes Mellitus	5
Impact of Selective Peroxisome Proliferator-Activated Receptor (PPAR)-α Modulators and Fibrates on Microvascular Disease: Is There Still Room?	5
Free Cholesterol Bioavailability and Atherosclerosis	5
Statin Use and Coronary Artery Calcification: a Systematic Review and Meta-analysis of Observational Studies and Randomized Controlled Trials	5
Renal Denervation for Hypertension: Current Evidence and Clinical Perspectives	5
Social Media and Cardiovascular Health: Implications for Women	5